• Je něco špatně v tomto záznamu ?

Highest ambulatory speed using Lokomat gait training for individuals with a motor-complete spinal cord injury: a clinical pilot study

L. van Silfhout, Z. Váňa, J. Pĕtioký, MJR. Edwards, RHMA. Bartels, H. van de Meent, AJF. Hosman,

. 2020 ; 162 (4) : 951-956. [pub] 20191224

Jazyk angličtina Země Rakousko

Typ dokumentu klinická studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028289

BACKGROUND: Motor impairment and loss of ambulatory function are major consequences of a spinal cord injury (SCI). Exoskeletons are robotic devices that allow SCI patients with limited ambulatory function to walk. The mean walking speed of SCI patients using an exoskeleton is low: 0.26 m/s. Moreover, literature shows that a minimum speed of 0.59 m/s is required to replace wheelchairs in the community. OBJECTIVE: To investigate the highest ambulatory speed for SCI patients in a Lokomat. METHODS: This clinical pilot study took place in the Rehabilitation Center Kladruby, in Kladruby (Czech Republic). Six persons with motor-complete sub-acute SCI were recruited. Measurements were taken at baseline and directly after a 30 min Lokomat training. The highest achieved walking speed, vital parameters (respiratory frequency, heart rate, and blood pressure), visual analog scale for pain, and modified Ashworth scale for spasticity were recorded for each person. RESULTS: The highest reached walking speed in the Lokomat was on average 0.63 m/s (SD 0.03 m/s). No negative effects on the vital parameters, pain, or spasticity were observed. A significant decrease in pain after the Lokomat training was observed: 95% CI [0.336, 1.664] (p = 0.012). CONCLUSION: This study shows that it is possible for motor-complete SCI individuals to ambulate faster on a Lokomat (on average 0.63 m/s) than what is currently possible with over-ground exoskeletons. No negative effects were observed while ambulating on a Lokomat. Further research investigating walking speed in exoskeletons after SCI is recommended.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028289
003      
CZ-PrNML
005      
20210114153432.0
007      
ta
008      
210105s2020 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00701-019-04189-5 $2 doi
035    __
$a (PubMed)31873795
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a van Silfhout, Lysanne $u Department of Surgery, Radboudumc, Nijmegen, the Netherlands. lysannevansilfhout@live.nl.
245    10
$a Highest ambulatory speed using Lokomat gait training for individuals with a motor-complete spinal cord injury: a clinical pilot study / $c L. van Silfhout, Z. Váňa, J. Pĕtioký, MJR. Edwards, RHMA. Bartels, H. van de Meent, AJF. Hosman,
520    9_
$a BACKGROUND: Motor impairment and loss of ambulatory function are major consequences of a spinal cord injury (SCI). Exoskeletons are robotic devices that allow SCI patients with limited ambulatory function to walk. The mean walking speed of SCI patients using an exoskeleton is low: 0.26 m/s. Moreover, literature shows that a minimum speed of 0.59 m/s is required to replace wheelchairs in the community. OBJECTIVE: To investigate the highest ambulatory speed for SCI patients in a Lokomat. METHODS: This clinical pilot study took place in the Rehabilitation Center Kladruby, in Kladruby (Czech Republic). Six persons with motor-complete sub-acute SCI were recruited. Measurements were taken at baseline and directly after a 30 min Lokomat training. The highest achieved walking speed, vital parameters (respiratory frequency, heart rate, and blood pressure), visual analog scale for pain, and modified Ashworth scale for spasticity were recorded for each person. RESULTS: The highest reached walking speed in the Lokomat was on average 0.63 m/s (SD 0.03 m/s). No negative effects on the vital parameters, pain, or spasticity were observed. A significant decrease in pain after the Lokomat training was observed: 95% CI [0.336, 1.664] (p = 0.012). CONCLUSION: This study shows that it is possible for motor-complete SCI individuals to ambulate faster on a Lokomat (on average 0.63 m/s) than what is currently possible with over-ground exoskeletons. No negative effects were observed while ambulating on a Lokomat. Further research investigating walking speed in exoskeletons after SCI is recommended.
650    _2
$a dospělí $7 D000328
650    _2
$a terapie cvičením $x přístrojové vybavení $x metody $7 D005081
650    _2
$a exoskeleton $7 D000067190
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a svalová spasticita $7 D009128
650    _2
$a pilotní projekty $7 D010865
650    _2
$a robotika $x přístrojové vybavení $x metody $7 D012371
650    _2
$a poranění míchy $x patologie $x rehabilitace $x terapie $7 D013119
650    12
$a rychlost chůze $7 D000072797
655    _2
$a klinická studie $7 D000068397
655    _2
$a časopisecké články $7 D016428
700    1_
$a Váňa, Zdenĕk $u Rehabilitation Centre Kladruby, Kladruby, Czech Republic.
700    1_
$a Pĕtioký, Jakub $u Third Faculty of Medicine, Neurosciences, Charles University, Prague, Czech Republic.
700    1_
$a Edwards, Michael J R $u Department of Trauma Surgery, Radboudumc, Nijmegen, the Netherlands.
700    1_
$a Bartels, Ronald H M A $u Department of Neurosurgery, Radboudumc, Nijmegen, the Netherlands.
700    1_
$a van de Meent, Henk $u Department of Rehabilitation, Radboudumc, Nijmegen, the Netherlands.
700    1_
$a Hosman, Allard J F $u Department of Orthopedic Surgery, Radboudumc, Nijmegen, the Netherlands.
773    0_
$w MED00009022 $t Acta neurochirurgica $x 0942-0940 $g Roč. 162, č. 4 (2020), s. 951-956
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31873795 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114153429 $b ABA008
999    __
$a ok $b bmc $g 1608624 $s 1119469
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 162 $c 4 $d 951-956 $e 20191224 $i 0942-0940 $m Acta neurochirurgica $n Acta Neurochir $x MED00009022
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace